Cellular Therapy Protocols: A Complete Guide

Introduction to Cellular Therapies in Wound Care

Cellular and tissue-based products (CTPs) have revolutionized the treatment of chronic, non-healing wounds. These advanced therapies provide the scaffolding, growth factors, and cellular components necessary to restart the healing process in wounds that have failed conventional treatment.

This comprehensive guide covers the protocols, indications, and best practices for implementing cellular therapies in your wound care practice.

Understanding Cellular Therapies

Types of Products

1. Human Skin Allografts

Derived from donated human skin

Contains multiple skin layers

Provides structural matrix and growth factors

2. Amniotic Membrane Products

Derived from placental tissue

Rich in growth factors and cytokines

Available in various formulations

3. Bioengineered Skin Substitutes

Laboratory-produced living tissue

May contain living cells or acellular matrix

Designed to promote healing

Mechanism of Action

Cellular therapies work through multiple mechanisms:

• Providing scaffolding for cell migration
• Delivering growth factors that stimulate healing
• Modulating inflammation in the wound bed
• Promoting angiogenesis (new blood vessel formation)
• Recruiting host cells to the wound site

Patient Selection Criteria

Appropriate Candidates

Cellular therapies are typically indicated for:

• Chronic wounds that have failed 4+ weeks of standard care
• Diabetic foot ulcers
• Venous leg ulcers
• Pressure injuries
• Surgical wounds that won't heal

Contraindications

Relative contraindications may include:

• Active wound infection
• Inadequate blood supply
• Uncontrolled diabetes
• Immunosuppression
• Sensitivity to product components

Pre-Application Protocol

Week 1-4: Wound Bed Preparation

Before applying cellular products, optimize the wound bed:

• Debridement: Remove necrotic tissue and biofilm
• Infection control: Treat any clinical infection
• Moisture balance: Achieve appropriate moisture levels
• Edge management: Address rolled or undermined edges

Assessment Checklist

• [ ] Wound measurements documented
• [ ] Photography completed
• [ ] Infection ruled out or treated
• [ ] Vascular status assessed
• [ ] Nutritional status optimized
• [ ] Offloading plan in place (for DFUs)

Application Protocols

Standard Application Procedure

Step 1: Wound Preparation

Clean wound with saline or appropriate cleanser

Sharp debridement if needed

Achieve hemostasis

Step 2: Product Preparation

Follow manufacturer's instructions for thawing/hydration

Do not allow product to dry out

Handle with sterile technique

Step 3: Application

Apply product to cover wound bed

Ensure contact with wound edges

May overlap edges by 1-2mm

Step 4: Dressing

Apply non-adherent primary dressing

Secure with appropriate secondary dressing

Consider compression for venous wounds

Reapplication Guidelines

Most cellular products require weekly reapplication until:

Wound is fully epithelialized

Maximum applications reached (per insurance)

Clinical decision to change therapy

Post-Application Care

Patient Instructions

• Keep dressing dry and in place
• Avoid bearing weight on wound (if applicable)
• Report signs of infection immediately
• Follow up as scheduled

Follow-up Protocol

Week 1 Post-Application:

Assess for adverse reactions

Measure wound size

Evaluate for infection

Weekly Thereafter:

Continue assessments

Document percent wound closure

Determine need for reapplication

Documentation Requirements

Medical Necessity

Document clearly:

Wound duration and previous treatments

Why standard care has failed

Expected benefit from cellular therapy

Per-Application Documentation

• Pre-treatment wound measurements
• Product applied (manufacturer, lot number)
• Application technique
• Post-treatment wound appearance
• Patient tolerance

Compliance Considerations

Legally Vetted Protocols

LINC Health provides protocols that have been:

Reviewed by healthcare attorneys

Aligned with CMS guidelines

Designed for audit defensibility

Common Compliance Pitfalls

• Applying to wounds that haven't failed standard care
• Inadequate documentation of wound measurements
• Missing infection assessments
• Failure to document medical necessity each visit

Expected Outcomes

With appropriate patient selection and protocol adherence:

• 60-70% of chronic wounds achieve closure
• 50% reduction in wound size by week 4
• Significant reduction in amputation risk for DFUs

Conclusion

Cellular therapies represent a powerful tool in the wound care arsenal. Success requires careful patient selection, meticulous technique, and thorough documentation. LINC Health's wound care programs provide the protocols, training, and compliance support needed to implement these therapies effectively.